ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184 | -15.6% | 8,884 | -23.6% | 0.00% | 0.0% |
| Q1 2023 | $218 | -99.8% | 11,628 | +158.5% | 0.00% | – |
| Q2 2021 | $110,000 | -44.7% | 4,499 | -41.7% | 0.00% | -100.0% |
| Q1 2021 | $199,000 | +22.8% | 7,711 | +154.7% | 0.00% | 0.0% |
| Q4 2020 | $162,000 | +362.9% | 3,028 | +257.1% | 0.00% | – |
| Q3 2020 | $35,000 | -27.1% | 848 | -13.9% | 0.00% | – |
| Q2 2020 | $48,000 | – | 985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |